Plasminogen activator inhibitor 1 (PAI-1) 4G/5G polymorphism-994

Test info

  
Plasminogen activator inhibitor 1 (PAI-1) 4G/5G polymorphism
  
994
  
LAB994
  
MSO
  
Plasminogen activator inhibitor (PAI-1)
Gene polymorphism
PAI-1 4G/5G Polymorphism
  

Deep vein thrombosis (DVT) and coronary artery disease (CAD) are associated with increased PAI-1 levels. Elevated PAI-1 levels may help predict risk of reinfarction in survivors of myocardial infarction, particularly in young individuals. PAI-1 levels tend to be lower in individuals with 4G/5G or 5G/5G genotype compared to a 4G/4G genotype.

Specimen

  
EDTA whole blood
  
  
1.0 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting

  

Lavender (EDTA), 4mL

 

  
ACD whole blood
  

Yellow ACD (A or B)

 

  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting

  

Yellow ACD (A or B)

  

Ambient (preferred) - 8 days

Refrigerated - 8 days

Performance

  
Esoterix Coagulation Lab (129100) via LabCorp (500309): R-NX
  
Mo, Th
  
7 - 11 days
  

Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) technologies

Clinical and Interpretive info

  

An interpretive report will be provided

Billing

  
81400
  
Yes
  
Result UNLOINC
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

Tracking

  
05/24/2019
  
05/24/2019
  
08/18/2022